 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Anil Nair, MDAssistant Professor of NeurologyPhone: 617.638.8456 Fax: 617.414.1197 Email: an@bu.edu Location: Robinson B - 7800 BackgroundDr. Nair graduated from Jawaharlal Institute before completing a residency in neurology at Temple University and Cleveland Clinic, Cleveland, OH. Following this, he completed a fellowship in Behavioral Neurology at the Mayo Clinic, Rochester, MN under Dr. Ronald Peterson. Dr. Nair is faculty at Boston University School of Medicine where he is an Assistant Professor. He is a board certified neurologist who sees neurology patients at the Boston Medical Center and Weymouth sites. Research InterestsDr. Nair's research interests are in early and preclinical detection, treatment and prevention of Alzheimer's disease, with special emphasis on MCI. Primarily he is a clinical trialist working with new drug treatments in AD. He also investigates genetics of Alzheimer's disease, with a special focus on genetic disclosure to at risk persons. He is also interested in Lewy body dementia, Primary Progressive Aphasia and Frontotemporal dementia from a clinical perspective. ADC RoleDr. Nair is a clinical investigator of the NIA-funded Alzheimer's Disease Center. He is the PI for the DHA study which evaluates a new drug for Alzheimer's disease, derived from fish oil. Dr. Nair is also investigator for several other Alzheimer's disease drug treatment trials, including ADAPT, Flurizan and IVIG, in which new medications are being tested for preventing Alzheimer's disease. He is also an investigator in the HOPE study. He is also involved with the REVEAL Study (Risk Evaluation and Education for Alzheimer's disease), a multi-center project funded by the National Human Genome Research Institute and the NIA to evaluate genetic risk assessment strategies for individuals at risk for Alzheimer's disease by disclosing their APOE information. He is also involved with the ADNI trial, which is an NIH funded, 5 year observational study of mild cognitive impairment and early Alzheimer’s disease, by repeated imaging, biological markers and clinical assessments to measure the progression. Awards/MembershipsDr. Nair is a member of the American Academy of Neurology. He has also received various awards including Jawaharlal Nehru Foundation Scholarship, Indian Institute of Science Assistantship, Genesis Prize in Neural Networks and Computational Design, National Talent Search Scholarship. He is also the recipient of the Helen Bader Foundation Memory Clinic Grant. InterviewsNair A. "Top 5 Dementia Myths Debunked." Hosted by Rick Turner. PublicationsNair A, Chen C, Hiraki S, Chung W, Roberts JS, Green RC. Race and self-perceived risk of Alzheimer’s disease is associated with dropout in the REVEAL study disclosing genetic susceptibility. Alzheimer’s and Dementia (Journal of the Alzheimer’s Association); 2007; 3(3, S169): 257. Nair A, Green RC. Century of Alzheimer’s: Progress and Pitfalls. Invited review in issue on the centenary of Alzheimer’s disease, Practical Neurology; 2006; 5(9): 22-29. [PDF] Widdess-Walsh P, Nair A, Staugaitis S. Lymphoma-associated progressive dementia. Helix Dementia Reviews; 2006; 8(3): 2-4. Boeve B, Shiung M, Jack C, Knopman D, Smith G, Ivnik R, Nair A, Lewis J, Hutton M, Wszolek Z, Murrell J, Waclawik A, Koppikar V , Kodras R, Duff K , Kuntz K, Ghetti B, Petersen R. Changes in the Rate of Functional, Clinical, and Radiologic Progression in FTDP-17 Associated With Lithium Administration. Article submitted for publication Baker M, Dickson DW, Lin W, DeLucia M, Kumar N, Hutton M, Ellison J, Fredericks GV, Duffy J, Woodruff BK, Nair AK, Kuntz K, Jack CR, Westmoreland BF, Boeve BF. Characterization of a Kindred with a Novel Twelve Octapeptide Repeat Insertion in the Prion Protein Gene. Article submitted for publication Boeve BF, Tremont-Lukats IW, Waclawik AJ, Murrell JR, Hermann B, Jack CR Jr, Shiung MM, Smith GE, Nair A, Lindor N, Koppikar V, Ghetti B. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the S305N tau mutation. Brain. 2005 Apr;128(Pt 4):752-72. [PDF] Widdess-Walsh P, Nair A, Staugaitis SM. Primary CNS lymphoma (Diffuse large B-cell lymphoma). Brain Pathology. October 2004 Nair A, Boeve BF, Smith GE, Ivnik RJ , Knopman DS, Hutton ML, Baker MC, Edland SC, Kuntz K, Petersen RC, Neuropsychological Findings in Mild Frontotemporal Dementia Associated With Tau Mutations. Presented at 9th International Conference on Alzheimer's Disease and Related Disorders, Philadelphia, PA, USA, July 17-22, 2004. Nair A, Boeve BF, Edland SD, Jack CR, Slusser TC, Knopman DS, Petersen RC. Hippocampal Asymmetry Predicts Neuropsychological Performance in Alzheimer's Disease. Abstract presented at American Academy of Neurology, Mayo Clinic, Rochester, MN, April 29 2004. Polysomnographic Studies in Congestive Cardiac Failure. Nair A. Thesis Submitted to Pondicherry University, India |
|
 |
 |
 |
 |
 |
|